Search results

Order by most recent / most popular / relevance

Results: 1-10 of 262

Canadian cleantech goes global: key considerations in international licensing

Gowling Lafleur Henderson LLP
-
Canada
-
April 22 2013

The rising cost of energy and resources and the transition to a low-carbon economy have driven research, development and investment efforts in clean

Integration of IP counsel and legal counsel services to expedite technology commercialization

Gowling Lafleur Henderson LLP
-
Canada
-
April 22 2013

The severe global economic recession of 2008 and the explosion in the availability, distribution and access to information electronically via the

Supreme Court of Canada rules on copyright in freelance articles

Gowling Lafleur Henderson LLP
-
Canada
-
August 30 2007

In Robertson v. Thomson Corp., 2006 SCC 43, the Supreme Court of Canada, in a 5-4 majority decision, has determined that newspaper publishers are not necessarily legally entitled to republish in electronic databases freelance articles acquired for publication in the original newspapers

Russia launches the IP Court

Gowling Lafleur Henderson LLP
-
Russia
-
April 22 2013

Russia demonstrated its commitment to intellectual property protection by introducing a specialized intellectual rights court (the IP Court). The

Data protection: defining innovative drug in Canada

Gowling Lafleur Henderson LLP
-
Canada
-
April 22 2013

Canada amended its Data Protection Regulations in 2006 to provide protection for innovative drugs in a second attempt to implement Canada's 1994

Celgene Corporation v Canada (AG) - Supreme Court of Canada grants leave to appeal

Gowling Lafleur Henderson LLP
-
Canada
-
May 21 2010

The Supreme Court of Canada has granted Celgene Corporation's application for leave to appeal the decision of a majority of the Federal Court of Appeal regarding the jurisdiction of the Patented Medicine Prices Review Board

Apotex v Sanofi, case management directions on the late disclosure of documents or information

Gowling Lafleur Henderson LLP
-
Canada
-
May 21 2010

Prior to a case management conference within a streamlined case, the Prothonotary ordered the parties to make submissions at the conference on the question of whether a date should be set after which the parties required either consent of the other party or leave of the Court to serve a supplementary affidavit of documents or a corrected or completed information in answer to a discovery question

Protecting technology: patenting and trade secrecy considerations

Gowling Lafleur Henderson LLP
-
Canada, USA
-
May 30 2008

Competitive pressures and the promise of economic rewards spur technology development across all business spaces in today’s market economy

Sanofi-Aventis v Pharmascience; 55.2 proceeding; motion to limit NOA based on issue estoppel; October 17, 2007 - ramipril

Gowling Lafleur Henderson LLP
-
Canada
-
October 25 2007

The innovator brought a motion seeking a determination that the generic was precluded from making further allegations of invalidity by the doctrines of abuse of process, res judicata andor issue estoppel, on the basis that the same generic company had made a previous allegation of invalidity that had been found to have no merit

Trade-Marks Office tightens Official Mark practice after Federal Court sees unfairness in Registrar’s decision

Gowling Lafleur Henderson LLP
-
Canada
-
May 30 2008

In See You In Canadian Athletes Fund Corporation v. Canadian Olympic Committee, 2007 FC 406, the Federal Court of Canada quashed the Registrar’s decision to grant Official Mark protection in the absence of adequate evidence of adoption and use of the marks

next >

Search results

Canadian cleantech goes global: key considerations in international licensing

Integration of IP counsel and legal counsel services to expedite technology commercialization

Supreme Court of Canada rules on copyright in freelance articles

Russia launches the IP Court

Data protection: defining innovative drug in Canada

Celgene Corporation v Canada (AG) - Supreme Court of Canada grants leave to appeal

Apotex v Sanofi, case management directions on the late disclosure of documents or information

Protecting technology: patenting and trade secrecy considerations

Sanofi-Aventis v Pharmascience; 55.2 proceeding; motion to limit NOA based on issue estoppel; October 17, 2007 - ramipril

Trade-Marks Office tightens Official Mark practice after Federal Court sees unfairness in Registrar’s decision

Current Search

Suggested Facets

Author

Jurisdiction

Workarea